Paugh et al. (2016) reported that decreased methylation of the Caspase-1 promoter results in increased transcription and activation of NLRP3 and Caspase1, which cleaves the glucocorticoid receptors used in the treatment of ALL, what suggests their association with relapse episodes10, 39. The gene discussed is CASP1; the disease is acute lymphoblastic leukemia.